MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 111 filers reported holding MYOVANT SCIENCES LTD in Q4 2021. The put-call ratio across all filers is 3.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,045,000 | -44.1% | 84,086 | -40.1% | 0.01% | -33.3% |
| Q1 2022 | $1,869,000 | -35.9% | 140,323 | -25.0% | 0.01% | -35.7% |
| Q4 2021 | $2,914,000 | -38.8% | 187,167 | -11.8% | 0.01% | -44.0% |
| Q3 2021 | $4,760,000 | -12.7% | 212,116 | -11.4% | 0.02% | -10.7% |
| Q2 2021 | $5,450,000 | +17.2% | 239,360 | +5.9% | 0.03% | +7.7% |
| Q1 2021 | $4,650,000 | -23.8% | 225,950 | +2.3% | 0.03% | -27.8% |
| Q4 2020 | $6,102,000 | +83.0% | 220,915 | -6.9% | 0.04% | +63.6% |
| Q3 2020 | $3,334,000 | -54.3% | 237,326 | -32.9% | 0.02% | -56.9% |
| Q2 2020 | $7,293,000 | +193.4% | 353,707 | +7.4% | 0.05% | +131.8% |
| Q1 2020 | $2,486,000 | -15.8% | 329,250 | +73.1% | 0.02% | +10.0% |
| Q4 2019 | $2,952,000 | – | 190,211 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 3,474,645 | $53,926,000 | 68.07% |
| Eventide Asset Management | 4,126,131 | $64,038,000 | 1.80% |
| VHCP Management III, LLC | 455,255 | $7,066,000 | 1.40% |
| Ghost Tree Capital, LLC | 450,000 | $6,984,000 | 1.33% |
| Cormorant Asset Management, LP | 2,000,000 | $31,040,000 | 1.24% |
| Bellevue Group AG | 4,815,109 | $74,730,000 | 1.18% |
| Values First Advisors, Inc. | 72,417 | $1,124,000 | 1.08% |
| Parkman Healthcare Partners LLC | 99,413 | $1,543,000 | 0.44% |
| Matisse Capital | 32,750 | $508,000 | 0.36% |
| VHCP Management II, LLC | 76,768 | $1,191,000 | 0.31% |